Novel A20 based therapeutic strategies to fight lung cancer

被引：0
作者：
Homolya, Monika [1 ]
Schwab, Max [1 ]
Machtinger, Michael [1 ]
Casanova, Emilio [1 ,2 ]
Moll, Herwig [1 ,2 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Comprehens Canc Ctr, Vienna, Austria
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
2237 - P1.
引用
收藏
页码：553 / 553
页数：1
相关论文
共 50 条
[21]   Sunvozertinib: shining light on lung cancer's exon 20 fight [J].
Mitsudomi, Tetsuya .
TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (02) :334-340
[22]   Novel Strategies to Fight Endometriosis [J].
Maduro, Maria Rosa .
REPRODUCTIVE SCIENCES, 2018, 25 (09) :1305-1306
[23]   Novel Strategies to Fight Endometriosis [J].
Maria Rosa Maduro .
Reproductive Sciences, 2018, 25 :1305-1306
[24]   The Role of A20 in Cancer: Friend or Foe? [J].
Lee, Jinju ;
Cheong, Heesun .
CELLS, 2025, 14 (07)
[25]   Novel therapeutic strategies in development for prostate cancer [J].
Harzstark, Andrea L. ;
Ryan, Charles J. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (01) :13-22
[26]   Novel epigenetic therapeutic strategies and targets in cancer [J].
Babar, Quratulain ;
Saeed, Ayesha ;
Tabish, Tanveer A. ;
Pricl, Sabrina ;
Townley, Helen ;
Thorat, Nanasaheb .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2022, 1868 (12)
[27]   Novel antibody therapeutic strategies for breast cancer [J].
Karagiannis, Sophia N. .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 :S19-S19
[28]   An Overview of Endometrial Cancer with Novel Therapeutic Strategies [J].
Kuhn, Theresa M. ;
Dhanani, Saeeda ;
Ahmad, Sarfraz .
CURRENT ONCOLOGY, 2023, 30 (09) :7904-7919
[29]   Novel Strategies and Therapeutic Advances for Bladder Cancer [J].
Ehrlich, Matthew I. ;
Fox, Robert D. ;
Runcie, Karie D. ;
Stein, Mark N. ;
Wei, Alexander Z. .
CANCERS, 2025, 17 (13)
[30]   A20 as a Potential Therapeutic Target for COVID-19 [J].
Wu, Yongyao ;
He, Lilan ;
Li, Rong ;
Li, Jiuxuan ;
Zhao, Qing ;
Shao, Bin .
IMMUNITY INFLAMMATION AND DISEASE, 2025, 13 (01)
12345